Open the mobile version, with barcode scanning
Class II Terminated

MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceutic…

Why: Lack of Assurance of Sterility

Company
Teva Pharmaceuticals USA
Parsippany, NJ, United States
Reported
Jan 19, 2022
Recall started
Dec 31, 2021
Ended
Jun 4, 2024
Where sold
Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
Amount
7,400 cartons
Full product description
MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons.
Lots / codes affected
Lot # 100022393, exp 09/2022

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.